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Background. There is insufficient data in Pakistan and in South Asia regarding paediatric COVID-19 demographics and related
parameters. The main aim of this study was to assess the paediatric population exposed to SARS-CoV-2 infection, their clinical
parameters, risk factors, and outcome. Methods. This was a descriptive retrospective study conducted at the Pakistan Institute of
Medical Sciences and Federal General Hospital Islamabad from 23rd July 2020 to 22nd August 2020. All paediatric contacts (≤13
years) of one hundred adult COVID-19 patients were included. Data of the index cases was taken from the medical records.
Paediatric data was collected on the phone using a predesigned proforma. Results. There were 137 paediatric contacts of 100
adult COVID-19 index cases. The index cases were predominantly males (67%) and belonged to the middle socioeconomic class
(89%), and 14% succumbed to the disease. Females had more paediatric contacts. The mean age of contacts was 6.6 years, and
the majority (80%) developed no symptoms. Among the symptomatic contacts, fever and cough were the most common
symptoms. None of the contacts developed dyspnoea or required hospitalization. Majority of the contacts had been vaccinated
with the BCG vaccine. Testing for COVID-19 was done in only 77 (56%) contacts, 25 (32%) by the government team, and 52
(67%) privately. A higher number of symptomatic contacts were positive (15/17 (88%)) as compared to that of the
asymptomatic contacts (6/60 (10%)) (p = 0:002). Development of symptoms in the contacts was associated with the history of
respiratory illnesses, recurrent infections, use of hematinics, a positive COVID-test result, and health professionals being index
cases (p ≤ 0:01). Parents with higher education and in the health profession and the families of symptomatic contacts reported
better compliance with quarantine regulations. Conclusion. A significant number of children were exposed to adult COVID-19
patients. Most paediatric contacts remained asymptomatic. Children with preexisting medical conditions and with parents in
health profession were susceptible to infection.
1. Introduction
A new coronavirus was identified in December 2019 in
Wuhan, Hubei Province, China, among patients exhibiting
respiratory symptoms and a history of exposure to the Hua-
nan seafood market [1, 2]. The World Health Organization
(WHO) announced it as a public health emergency of inter-
national concern and named the virus as severe acute respira-
tory syndrome coronavirus 2 (SARS-CoV-2) and the disease
as coronavirus disease 2019 (COVID-19) [1]. The age of
infected people ranges from 1.5 days to 96 years, and both
genders seem to be equally affected. The groups at high risk
of severe disease and death are the elderly with underlying
conditions such as diabetes, hypertension, and
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cardiovascular disease. At the peak of the outbreak, children
are involved too, including neonates [3, 4].
Most of the children with COVID-19 have low morbid-
ity, and many develop mild symptoms or are asymptomatic,
similar to that observed for severe acute respiratory syn-
drome (SARS) and Middle East respiratory syndrome
(MERS). The few severe cases have usually exhibited under-
lying or coexisting medical conditions [5]. Younger age,
underlying pulmonary pathology, and immunocompromis-
ing conditions have been associated with serious outcomes
with non-SARS-CoV-2 coronavirus infections in children,
and the same pattern is reflected in SARS-CoV-2 infection
[6].
The debate that children may play a major role in
community-based viral transmission is still ongoing. Avail-
able data suggest that children may have more upper respira-
tory tract involvement (including nasopharyngeal carriage)
rather than lower respiratory tract involvement [4]. There
is also evidence of fecal shedding in the stool for several
weeks after diagnosis, leading to concern about fecal-oral
transmission of the virus [7]. There has been constant change
of views on this point with latest evidence in favor of children
not being sources of transmission and thus reopening of
schools and daycares can be safely considered [8].
There is insufficient data in Pakistan and in South Asia
regarding paediatric COVID-19 demographics and related
parameters. The main aim of this study was to assess the pae-
diatric population exposed to SARS-CoV-2 infection, their
clinical parameters, risk factors, and outcome.
2. Methods
This retrospective descriptive study was conducted at the
Pakistan Institute of Medical Sciences and Federal General
Hospital Islamabad. Ethical approval was taken from the eth-
ical committee of the mentioned institutes. Our inclusion cri-
teria were all adult patients with COVID-19 admitted at one
of the Corona wards at the Pakistan Institute of Medical Sci-
ences, Islamabad, during May 2020-August 2020. A total of
114 patients were admitted during this period. These patients
were contacted on telephone for an informed consent. For
patients who had expired, consent was obtained from their
next of kin. Fourteen patients refused participation and were
excluded from the study. Medical records of these 100
patients who gave their consent were obtained from the Paki-
stan Institute of Medical Sciences.
The paediatric contacts of these patients were identified
on the telephone; data was collected on the phone and
entered on a predesigned proforma. Paediatric contact was
defined as any child from 1 month to 13 years of age exposed
from 2 to 14 days to a patient who was positive for COVID-
19 and the contact occurred while they were ill as outlined by
the National Institute of Health, Pakistan [9]. All children
≤ 13 years of age fulfilling the contact definition were
included in the study whereas children who did not meet
the contact definition or in whom complete information
was lacking were excluded.
Nonprobability random sampling was done. Sample size
was estimated based on literature review. The exact sample
size was not calculated due to the lack of data available for
paediatric patients in Pakistan at the time of study. Contact
tracing was defined as tests done by government teams by
tracing the contacts of COVID-19 cases, while it was labelled
as self-testing when contacts of COVID-19 patients got them
investigated on their own from different laboratories without
doctor advice.
Data was entered and analyzed using SPSS 26. Descrip-
tive statistics were performed to obtain frequency and per-
centages of categorical variables. Mean, standard deviation
(SD) was reported for continuous variables. Chi-square test
and independent t test were used for finding statistical signif-
icance among different variables. Binary logistic regression
analysis was carried out to identify factors associated with
the development of symptoms in the contacts. p value of
<0.05 was considered statistically significant.
3. Results
3.1. Characteristics of the Index Cases. A total of 100 adult
patients diagnosed with COVID-19 were included in our
study. All these patients had severe symptoms and hypoxia
and required hospital admission. The mean age was 51.4
years (±14.2). Table 1 shows the characteristics of the index
cases. There was predominance of males (67%, p = 0:001).
A large proportion of patients belonged to the middle socio-
economic class (89%, p ≤ 0:001). There was no difference
between males and females regarding their disease outcome.
Females, on average, had more paediatric contacts as com-
pared to males (p = 0:03). While most of the patients recov-
ered form COVID-19, 14% (n = 14) succumbed to the
disease.
3.2. Characteristics of the Paediatric Contacts. Figure 1 shows
the flow chart of involved contacts and their course of
involvement. Our study identified 137 contacts of ≤13 years
of age. Majority of the contacts (80%) developed no
symptoms.
Table 2 shows the characteristics of the contacts with and
without symptoms. The ages of the contacts ranged from 6
months to 13 years, with a mean age of 6:6 ± 3:6 years. The
contacts were exposed to the index cases from 2 to 7 days.
There was no difference in the duration of contact between
symptomatic and asymptomatic contacts. Among the symp-
tomatic contacts, fever and cough were the most common
symptoms. The other less common symptoms were head-
ache, diarrhea, and burning eyes. None of the contacts devel-
oped dyspnoea or required any hospitalization. Majority of
the contacts had been vaccinated with the BCG vaccine. Very
few had also been given the influenza vaccine. Some contacts
also suffered from previous respiratory or cardiac illness,
such as asthma, ventricular septal defect, and patent ductus
arteriosus. Although there was no statistical difference
between development of symptoms between contacts with
previous cardiac disease and healthy contacts, there was a sig-
nificant difference in the development of symptoms with pre-
vious respiratory disease (p = 0:01). Recurrent infections
were present in 6 contacts, and it was found that 4 of these
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were symptomatic, which was statistically significant
(p = 0:01).
Not all the contacts were tested for COVID-19. Testing
was done in 77 (56%) contacts. Out of them, 25 (32%) con-
tacts underwent contact tracing by the government team, of
which 5 (20%) turned out to be positive. Another 52 (67%)
contacts got testing done on their own from different labora-
tories, and of these, 16 (30.7%) came out positive. A higher
number of symptomatic contacts were positive (15/17
(88%)) as compared to the asymptomatic contacts (6/60
(10%)) (p = 0:002). The time of testing was not studied and
44% were not tested, so the actual number of positive cases
could not be exactly commented on.
By binary logistic regression analysis, respiratory ill-
nesses, recurrent infections, use of hematinics, and a positive
COVID-test result were significantly associated with the
development of symptoms among the contacts. The use of
hematinics was taken as a proxy for the presence of iron defi-
ciency anemia.
As mentioned previously, our index cases also included
health professionals (nurses or doctors) who were at greater
risk of exposure to the disease. Figure 2 shows the compari-
son of contacts between the health and nonhealth profes-
sionals. Among the contacts, 27 had one or both parents
who were health professional, and of these, 10 (37%) devel-
oped symptoms. Conversely, of the 110 contacts who had
no parent in the health profession, 17 (16%) developed
symptoms. This was found to be statistically significant
(p = 0:01) representing health professionals as index cases
being a risk factor for the transmission of COVID-19 to pae-
diatric contacts.
Figure 3 shows an overview of the compliance with quar-
antine regulation. More than half of the contacts (51%) failed
to follow quarantine regulations. Parents of the contacts with
higher education and in the health profession and the fami-
lies of symptomatic contacts reported better compliance with
quarantine regulations.
4. Discussion
This retrospective study was conducted to assess the spec-
trum of paediatric contacts of adult COVID-19 patients in
Islamabad, Pakistan. This study shows that a significant
number of children were exposed to adult patients. This also
confirms that the majority of the contacts were asymptom-
atic or had mild disease. The COVID-testing rate and follow-
ing of quarantine measures were around 50% in our study.
Table 1: Characteristics of the adult index cases with COVID-19.






Lower middle class (Rs20,000-50,000/month) 47
Upper middle class (Rs50,000-100000/month) 42





Characteristics according to gender
Outcome Males Females
Discharged from hospital, n (%) 57 (85%) 29 (88%) ns
Expired, n (%) 10 (15%) 4 (12%)
Number of contacts ∗ number of index cases per contact (total number of contacts) 0 ∗ 26 (0) 0 ∗ 13 (0)
1 ∗ 18 (18) 1 ∗ 5 (5)
2 ∗ 15 (30) 2 ∗ 4 (8)
3 ∗ 4 (12) 3 ∗ 4 (12)
4 ∗ 4 (16) 4 ∗ 2 (8)
5 ∗ 4 (20)
8 ∗ 1 (8)
Number of contacts per index case 1.13 1.84 0.03
n: number; ns: not significant. 1Chi-square tests for categorical variables, independent sample t-test for numerical variables. The p value indicates significant
difference with respect to gender and socioeconomic status of the adult index cases. In the lower section, the p value indicates difference between male and
female index cases with respect to mortality, and number of contacts per index case.
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In our study, the mean age of contacts was 6.6 years. It is
similar to the mean age of infected and admitted paediatric
patients [10, 11], while a meta-analysis [12] showed a higher
mean age of 8.9 years. Our study showed a higher male
involvement than females though there was no statistical dif-
ference in gender among symptomatic and asymptomatic
contacts. This is in accordance with the gender characteristic
of affected children by Dong et al. [13]. Each contact had
mean exposure of 4:18 ± 0:98 days with a slightly lesser dura-
tion of contact in symptomatic contacts though this differ-
ence was not statistically significant. In a study from China
[14], the duration of contact was 7-8 days while Huang
et al. [15] showed that a few hours of contact was also suffi-
cient for the transmission of disease in relatively younger
contacts. It shows that contacts of a confirmed case should
not be taken lightly and must be observed or traced for symp-
toms or testing. There was no history of foreign travel or
travel to the Sindh province (the most endemic region of
the country at that time) in any patient or contacts showing
local circulation of the virus in Rawalpindi and Islamabad.
Of the 100 adult COVID-19 patients, there were 137 con-
tacts with 1.3 contacts per patient. This association of contact
exposure has not been studied previously. Pakistani under-14
population is around 35.4% [ 16] which is at risk of infection.
In this study, 81% of contacts were asymptomatic and 19%
were symptomatic. A systematic review presenting data on
2914 paediatric patients with COVID-19 identified that
14.9% of children were asymptomatic [17]. Others have
reported 18% asymptomatic cases in a meta-analysis [18]
and 16% asymptomatic cases in a European cohort [19]. This
lower number of asymptomatic cohorts in these studies is
due to the fact that it is from all of the confirmed cases while,
in our study, only 56% underwent COVID testing, so the lab-
oratory confirmation in all symptomatic or asymptomatic
contacts could not be established. Among symptomatic con-
tacts, fever and cough were the most prevalent symptoms.
This is in accordance with other studies regarding symptoms
of COVID-19 in children [6, 7, 18]. The disease showed a
mild pattern and no admission or death in our study. Same
pattern is reflected by the pooled data from seven countries
[20].
Younger age and preexisting medical conditions appear
to render a higher risk for COVID-19 infections [21]. In
our study, some contacts suffered from previous cardiac or
respiratory illness or there was history of repeated infections.
Out of this, respiratory illness and recurrent infections were
statistically significant in terms of symptomatology though
we could not identify the exact diagnosis of infections in
these cases.
There is a lot of debate about decreased severity and lim-
iting mortality rate due to COVID-19 in countries where
BCG vaccination coverage is maximum [22]. It has been
observed that the BCG vaccine offers a certain degree of
cross-protection against viral illnesses through trained
immunity-related mechanisms [23, 24] forming the basis of
the observation of reduced disease severity in BCG-
vaccinated populations. Several multicenter studies suggest






























Figure 1: Flow chart of involved contacts and their course of involvement.
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and mortality with higher BCG vaccination status [25–27].
On the other hand, many studies have negated this idea
[28, 29]. Our study population was maximally vaccinated
for BCG, and a lower number of symptomatic contacts and
mild disease favor the protective effect of BCG vaccination
in COVID-19 infection. On the other hand, 4 (36%) of the
contacts who were given influenza vaccine developed symp-
toms, but 23 (22%) contacts who did not receive influenza
vaccine were symptomatic. However, this difference was
not statistically significant. Similar results have been docu-
mented by Salem et al. [30] but opposite findings shown
by Amato et al. [ 31] leaving us with no conclusive evi-
dence that the influenza vaccine confers any protection
against COVID-19.
In our study, health professionals comprised about 10%
of the total patients, and 37% of contacts of health profes-
sionals developed symptoms as compared to 16% contacts
who had no adult source from a health-related setting. This
Table 2: Characteristics of the paediatric contacts and the risk factors associated with development of symptoms.
Symptomatic Asymptomatic
Statistical significance∗
(n = 27) (n = 110)
Males (n) 17 58 ns
Females (n) 10 52
Age in years 6.7 (±3.9) 6.6 (±3.5) ns
Weight in kg, mean (±SD) 16 (±7.8) 22 (±10) ns
Duration of contact, days, mean (±SD) 4.1 (±0.8) 4.2 (±1) ns
Fathers’ education, n (%) ns
Uneducated 0 1 (1%)
Primary 2 (7%) 5 (5%)
High school 7 (26%) 25 (23%)
College graduate 6 (22%) 46 (42%)
Masters 3 (11%) 23 (21%)
Doctor 9 (33%) 10 (9%)
Mothers’ education, n (%) ns
Uneducated 1 (4%) 3 (3%)
Primary 3 (11%) 21 (19%)
High school 8 (30%) 25 (23%)
College graduate 8 (30%) 49 (45%)
Masters 2 (7%) 4 (4%)
Doctor 5 (19%) 4 (4%)
Nurse 0 4 (4%)
Symptoms, n (%)
Fever 25 (92%) 0
Cough 18 (67%) 0
Diarrhea 5 (19%) 0
Headache 3 (11%) 0
Flu-like symptoms 3 (11%) 0
Burning eyes 2 (7%) 0
Dyspnoea 0 0
BCG vaccinated, n (%) 27 (100%) 104 (95%) ns
Influenza vaccinated, n (%) 4 (15%) 7 (6%)
History of respiratory illness, n (%) 4 (15%) 3 (3%) 0.01
History of cardiac illness, n (%) 2 (7%) 2 (2%) ns
History of recurrent infections, n (%) 4 (15%) 2 (2%) 0.015
History of hematinic use, n (%) 4 (15%) 5 (5%) 0.002
Test done-public contact tracing, n 6 19 ns
Test done privately, n 11 41 ns
Positive tests, n (public & private) 15 (5 & 10) 6 (0 & 6) 0.002
∗Logistic regression with symptoms as dependent variable. n: number of cases; SD: standard deviation.
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is in accordance with the study by David Koh [32]. To our
knowledge, frequency of symptomatic contacts of health pro-
fessionals has not been studied before.
Iron metabolism and hyperferritenemia are being inten-
sively studied in severe COVID-19 infection. Studies in
adults reveal that anemia is a risk factor for severe COVID
disease [33]. Keeping this in view, hematinic use was assessed
in our paediatric contacts assuming that the children with
iron deficiency anemia would be taking it. In our study, more
contacts who were taking hematinics were symptomatic as
compared to those who were not taking it. This shows an
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Figure 2: Comparison of contacts of the health and nonhealth professionals. Higher number of contacts of the health professionals developed
symptoms (p = 0:01) representing health professionals as index cases being a risk factor for transmission of COVID-19 to paediatric contacts.
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Figure 3: An overview of the compliance with quarantine regulation. Parents of the contacts with higher education and in the health
profession and the families of symptomatic contacts reported better compliance with quarantine regulations (p ≤ 0:01).
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and anemia though we could not establish haemoglobin
values due to the lockdown. To our knowledge, this associa-
tion in the paediatric group has not been previously studied.
Frequency of COVID-19 testing in contacts was 56% in
our study. It seems to be quite high as compared to the lim-
ited capability of our country in terms of contact tracing
and testing [34]. This appears to be due to the small study
population having a relatively higher education level and
the majority belonging to the upper middle class, thus repre-
senting an informed and cautious subgroup.
The strength of the study is that it is a first study looking
into different parameters of paediatric contacts. Also, very lit-
tle is known about paediatric COVID-19 demographics in
Pakistan and South Asia prior to it, and this study gives an
insight to it. The limitation of our study is that it is a small-
scale study, and data was collected over the phone as contacts
could not be examined because of the lockdown.
5. Conclusion
A significant proportion of children were exposed to adult
COVID-19 patients. Cough and fever remained the common
symptoms of paediatric contacts as in paediatric patients.
Majority of paediatric contacts remained asymptomatic.
Children with preexisting medical conditions and with par-
ents in health profession were susceptible to infection. Quar-
antine measures were not adequately followed in our study.
In our region, paediatric contacts of adult COVID-19
patients had the same parameters as paediatric COVID-19
patients from all around the world.
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